What do red blood cells (RBCs), hyaline casts, and squamous epithelial cells on a urinalysis indicate, and how should this be managed?

Urinalysis Findings: RBCs, Hyaline Casts, and Squamous Cells

The presence of RBCs on urinalysis requires risk stratification using the 2025 AUA/SUFU system to determine whether cystoscopy and imaging are needed, while hyaline casts are generally benign and squamous cells typically indicate specimen contamination rather than pathology. 1

Red Blood Cells (RBCs) - Clinical Significance and Management

Defining True Hematuria

• Microscopic hematuria requires ≥3 RBCs per high-power field (HPF) on properly collected, uncontaminated urine specimens. 1, 2
• A dipstick-positive result without RBCs on microscopy does not constitute true hematuria and should not trigger urologic evaluation. 2
• Values below 3 RBCs/HPF are considered normal and require no further workup. 2

Risk Stratification (2025 AUA/SUFU Guidelines)

Low/Negligible Risk (0%-0.4% malignancy) - requires ALL criteria: 1

• 3-10 RBC/HPF
• Women <60 years OR men <40 years
• Never smoker or <10 pack-years
• No additional urothelial cancer risk factors

Intermediate Risk (0.2%-3.1% malignancy) - requires ONE OR MORE: 1

• 11-25 RBC/HPF
• Women ≥60 years OR men 40-59 years
• 10-30 pack-years smoking history
• Any additional risk factor for urothelial cancer

High Risk (1.3%-6.3% malignancy) - requires ONE OR MORE: 1

• 25 RBC/HPF

• Men ≥60 years (women cannot be high-risk based on age alone)

• 30 pack-years smoking history

• One or more risk factors PLUS any high-risk feature

Initial Evaluation Requirements

• Perform detailed history including smoking quantification (pack-years), occupational/environmental exposures, family history of urologic malignancies, and history of gross hematuria. 1
• Measure blood pressure and serum creatinine to assess for medical renal disease. 1
• Document irritative urinary symptoms and overall health status. 1

Distinguishing Glomerular vs. Non-Glomerular Sources

• Dysmorphic RBCs (especially acanthocytes) and RBC casts indicate glomerular origin with 90-100% specificity for glomerular disease. 3
• Dysmorphic RBCs are found in 94% of chronic glomerulonephritis cases when ≥5 RBCs/HPF are present. 4
• Non-glomerular hematuria typically shows uniform, non-dysmorphic RBCs. 5

Imaging and Cystoscopy Decisions

• Gross hematuria carries 30-40% malignancy risk and mandates full urologic evaluation including cystoscopy and imaging regardless of other factors. 6
• Microhematuria evaluation should be guided by risk stratification, with cystoscopy being critical since most hematuria-associated cancers are bladder cancers optimally detected by cystoscopy. 1
• Delays in bladder cancer diagnosis increase cancer-specific mortality by 34% and all-cause mortality by 15%. 1

Hyaline Casts - Clinical Significance

Interpretation

• Hyaline casts are the most common cast type and are generally benign, often seen in concentrated urine or after exercise. 7
• They can be present in normal individuals and do not necessarily indicate renal pathology. 7
• Nephrologists achieve moderate interobserver agreement (kappa = 0.52) for hyaline cast identification, making them one of the more reliably identified urinary structures. 8

When Hyaline Casts Suggest Pathology

• When found alongside other abnormal findings (dysmorphic RBCs, proteinuria, elevated creatinine), they may support renal parenchymal disease. 4
• In chronic glomerulonephritis and chronic renal failure, various cast types including hyaline casts are commonly present. 4

Squamous Epithelial Cells - Clinical Significance

Interpretation

• Squamous cells primarily indicate specimen contamination from the distal urethra, vagina, or external genitalia, not urinary tract pathology. 9
• Squamous cells were present in 94% of catheterized urine samples from women, yet none showed bacterial contamination, demonstrating they are not reliable indicators of contamination. 9
• In midstream clean-catch samples, squamous cells had only 21% predictive value for bacterial contamination. 9

Clinical Implications

• Do not use squamous cell presence to determine specimen adequacy or contamination—this is a common pitfall. 9
• Nephrologists achieve the best interobserver agreement for squamous cell identification (kappa = 0.54) compared to other urinary structures. 8
• Clinical laboratories may incorrectly report renal tubular epithelial cells as squamous cells, potentially missing important diagnostic information. 7

Critical Pitfalls to Avoid

• Never initiate hematuria workup based solely on dipstick positivity without microscopic confirmation of ≥3 RBCs/HPF. 2
• Do not rely solely on imaging for hematuria evaluation—cystoscopy is essential for detecting bladder cancer, the most common malignancy in this setting. 1
• Do not dismiss microhematuria in high-risk patients; risk stratification must guide evaluation intensity. 1
• Recognize that urine sediment interpretation is operator-dependent, with nephrologist-performed urinalysis showing 92.3% diagnostic accuracy versus 19-23% accuracy when interpreting laboratory reports alone. 7